| AMSTAR 2 | A Measurement Tool to Assess Systematic Reviews 2 |
| BP | Blood pressure |
| CCA | Corrected covered area |
| CERT | Consensus on Exercise Reporting Template |
| CGM | Continuous glucose monitoring |
| CI | Confidence interval |
| DBP | Diastolic blood pressure |
| FMD | Flow-mediated dilation |
| GRADE | Grading of Recommendations Assessment, Development and Evaluation |
| HDL-C | High-density lipoprotein cholesterol |
| iAUC | Incremental area under the curve |
| LDL-C | Low-density lipoprotein cholesterol |
| MAP | Mean arterial pressure |
| NEFA | Non-esterified fatty acids |
| PCOS | Polycystic ovary syndrome |
| PICOS | Population, Intervention, Comparator, Outcomes, Study design |
| PRIOR | Preferred Reporting Items for Overviews of Reviews |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| PROSPERO | International Prospective Register of Systematic Reviews |
| RCT | Randomized controlled trial |
| REML | Restricted maximum likelihood |
| RoB 2 | Risk of Bias 2 |
| ROBIS | Risk of Bias in Systematic Reviews |
| SBP | Systolic blood pressure |
| T2D | Type 2 diabetes |
| TC | Total cholesterol |
| TG | Triglycerides |
| TIDieR | Template for Intervention Description and Replication |
| VILPA | Vigorous intermittent lifestyle physical activity |
| VO2max | Maximal oxygen uptake |